Literature DB >> 12100903

Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart.

Iván P Uray1, John H Connelly, Vilmos Thomázy, Gregory L Shipley, William K Vaughn, O Howard Frazier, Heinrich Taegtmeyer, Peter J A Davies.   

Abstract

BACKGROUND: Experimental and clinical data suggest that the loss of membrane receptor tyrosine kinase (RTK) activity in cardiac myocytes results in increased frequency of apoptotic cell death and progression of heart failure. The goal of our study was to examine the expression characteristics of RTKs in ventricular myocardium obtained from patients before and after mechanical unloading.
METHODS: We extracted RNA from paired formalin-fixed, paraffin-embedded left ventricular tissue blocks obtained at the time of left ventricular assist device (LVAD) implantation and explantation from a cohort of 36 patients (median age 51 years). The duration of LVAD support ranged from 1 to 314 days (median 95 days), 17 patients had ischemic and 19 non-ischemic cardiomyopathy at the time of LVAD implantation. Using real-time reverse transcription-polymerase chain reaction (RT-PCR) we quantitated transcripts for atrial natriuretic factor (ANF) and tumor necrosis factor-alpha (TNF-alpha), markers of heart failure, and the RTKs Her2/neu, Her4 and gp130, regulators of cardiac cell survival.
RESULTS: In patients undergoing mechanical unloading, ANF and TNF-alpha mRNA levels were independently suppressed. Her2/neu, along with Her4 was upregulated, mostly in cases of ischemic cardiomyopathy, whereas gp130 levels decreased. Post-LVAD transcript levels of Her2 correlated tightly with gp130 in patients with non-pathologic entry values of gp130. Duration of treatment and age were also determining factors in the change of expression of these genes.
CONCLUSION: Real-time quantitative (Q)-RT-PCR can be used to quantitate gene expression in archival myocardial tissue blocks. Mechanical unloading leads to a re-adjustment of RTK transcript levels, but not their reverting to control values in heart failure patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100903     DOI: 10.1016/s1053-2498(02)00390-x

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  18 in total

1.  Neuregulin in heart failure : reverse translation from cancer cardiotoxicity to new heart failure therapy.

Authors:  C A Geisberg; D J Lenihan
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

2.  Trastuzumab.

Authors:  Annelies H Boekhout; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-05-31

Review 3.  Cytostatic drugs, neuregulin activation of erbB receptors, and angiogenesis.

Authors:  Nadia Hedhli; Kerry Strong Russell
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

4.  Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells.

Authors:  Balint L Balint; Attila Szanto; Andras Madi; Uta-Maria Bauer; Petra Gabor; Szilvia Benko; Laszlo G Puskás; Peter J A Davies; Laszlo Nagy
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  The growth factor receptor ERBB2 regulates mitochondrial activity on a signaling time scale.

Authors:  Nirav Patel; Antoni Barrientos; Ralf Landgraf
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

6.  Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways.

Authors:  Polina Sysa-Shah; Carlo G Tocchetti; Manveen Gupta; Peter P Rainer; Xiaoxu Shen; Byung-Hak Kang; Frances Belmonte; Jian Li; Yi Xu; Xin Guo; Djahida Bedja; Wei Dong Gao; Nazareno Paolocci; Rutwik Rath; Douglas B Sawyer; Sathyamangla V Naga Prasad; Kathleen Gabrielson
Journal:  Cardiovasc Res       Date:  2015-12-21       Impact factor: 10.787

7.  Endothelium-derived neuregulin protects the heart against ischemic injury.

Authors:  Nadia Hedhli; Qunhua Huang; April Kalinowski; Monica Palmeri; Xiaoyue Hu; Raymond R Russell; Kerry S Russell
Journal:  Circulation       Date:  2011-05-09       Impact factor: 29.690

8.  The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction.

Authors:  Saghir Akhtar; Ibrahim Fadil Benter
Journal:  Bioimpacts       Date:  2013-01-26

9.  Myocardial oxidative metabolism and protein synthesis during mechanical circulatory support by extracorporeal membrane oxygenation.

Authors:  Colleen M O'Kelly Priddy; Masaki Kajimoto; Dolena R Ledee; Bertrand Bouchard; Nancy Isern; Aaron K Olson; Christine Des Rosiers; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

Review 10.  Neuregulin in cardiovascular development and disease.

Authors:  Oghenerukevwe Odiete; Michael F Hill; Douglas B Sawyer
Journal:  Circ Res       Date:  2012-10-26       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.